Dr. Shivaani Kummar, MD
Claim this profileOregon Health and Science University
Area of expertise
Solid Tumors
Shivaani Kummar, MD has run 11 trials for Solid Tumors. Some of their research focus areas include:
Pancreatic Cancer
Shivaani Kummar, MD has run 8 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
Oregon Health And Science University
Oregon Health & Science University
Clinical Trials Shivaani Kummar, MD is currently running
SW-682
for Solid Tumors
This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Recruiting
1 award
Phase 1
6 criteria
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting
1 award
Phase 1 & 2
5 criteria
More about Shivaani Kummar, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Shivaani Kummar, MD has experience with
- Pembrolizumab
- Checkpoint Inhibitor Therapy
- Axatilimab
- Paclitaxel
- Retifanlimab
- SGN-CD228A
Breakdown of trials Shivaani Kummar, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shivaani Kummar, MD specialize in?
Shivaani Kummar, MD focuses on Solid Tumors and Pancreatic Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Shivaani Kummar, MD currently recruiting for clinical trials?
Yes, Shivaani Kummar, MD is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Shivaani Kummar, MD has studied deeply?
Yes, Shivaani Kummar, MD has studied treatments such as Pembrolizumab, Checkpoint Inhibitor Therapy, Axatilimab.
What is the best way to schedule an appointment with Shivaani Kummar, MD?
Apply for one of the trials that Shivaani Kummar, MD is conducting.
What is the office address of Shivaani Kummar, MD?
The office of Shivaani Kummar, MD is located at: Oregon Health and Science University, Portland, Oregon 97239 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.